Annual Report 2011-12.pdf - Performance Management Division
Annual Report 2011-12.pdf - Performance Management Division
Annual Report 2011-12.pdf - Performance Management Division
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Quality <strong>Management</strong> System<br />
National Dope Testing Laboratory has developed and implemented its <strong>Management</strong> System to<br />
ensure quality of sample testing meeting the regulatory requirements and its customer's<br />
expectations. The quality manual has been developed in accordance with the ISO/IEC17025:2005<br />
Standard and International Standard for Laboratories (Version 6.0) January 2009. The sample<br />
testing methodology is adopted as per WADA guidelines and the testing methods are upgraded as<br />
per the need.<br />
External and internal audits are carried out on regular basis as per National Accreditation Board<br />
of Laboratories (NABL) requirements for the continuation of ISO/IEC17025:2005 accreditation.<br />
ISO Surveillance audit (External Audit)<br />
The ISO Surveillance audit of Biological activities and Desktop audit of Chemical activities was<br />
nd<br />
held on 21-22 September <strong>2011</strong>. The two member audit team recommended for the continuation of<br />
accreditation, which was later approved by NABL accreditation committee.<br />
Internal audit<br />
In order to review the functional status and quality system of NDTL, internal audits were<br />
conducted by trained internal assessors as per the approved annual schedule.<br />
WADA-Indian Pharmaceutical Companies Cooperation<br />
WADA-Indian Pharmaceutical Companies Cooperation was done to explore the possibility of<br />
cooperation between WADA and Indian Pharmaceutical companies on voluntary basis to share<br />
information which would show India's further commitment to be in the forefront of its mission to<br />
fight against doping. In this regard, Dr. Olivier Rabin, WADA Director, Science visited NDTL<br />
st<br />
st<br />
India on 31 October-1 November, <strong>2011</strong> to have a meeting with Pharmaceutical Companies in<br />
India (Ranbaxy Pharmaceuticals, Cipla, Dr. Reddy's Lab), renowned pharmacologists from All<br />
India Institute of Medical Sciences (AIIMS), Indian Council of Medical Research (ICMR), Indian<br />
Pharmacopeial Commission, and officials of NADA.<br />
Bilateral Cooperation<br />
A. International<br />
NDTL has entered in bilateral cooperation with two premier labs in the world which are Drug<br />
Control Centre, Kings College, and London and Anti doping lab, Rome, Italy.<br />
In addition, the possibility of cooperation with other WADA accredited anti-doping laboratory in<br />
South Africa is being explored. Areas of cooperation would include sharing of knowledge for<br />
improvement in testing protocol, exchange of staff between institutes and to work on research<br />
projects.<br />
98 ✦ Department of Youth Affairs & Sports